If you've been living with PCOS for any length of time, you've probably come across the word "inositol" at some point — scrawled in a TikTok comment, buried in a Reddit thread at midnight, or mentioned by a naturopath when your GP had nothing new to offer.

And maybe you've wondered: is this actually worth my time? Or is it another wellness buzzword dressed up in scientific language?

Here's the thing. The research on this is actually pretty clear — and it's been building for years.

Myo-inositol isn't a trend. It's one of the most studied natural compounds in PCOS management, with a growing body of clinical evidence supporting its role in insulin sensitivity, hormonal balance, ovulation, and more. This guide covers what it is, how it works, what the science says, and how to use it effectively.

No fluff. No miracle claims. Just clear, honest information — because that's what you deserve.

Inositol is a naturally occurring carbocyclic sugar produced by the body. It acts as a second messenger in cellular signalling, helping the body respond to hormones like insulin and FSH.

Your body makes it. You also get it from foods like citrus fruits, beans, nuts, and wholegrains. But here's the catch: for many women with PCOS, dietary intake isn't enough — and absorption can be impaired, meaning levels stay low even with a reasonably balanced diet.

There are nine forms of inositol in total, but two matter most for PCOS:

• Myo-inositol (MI) — the most abundant form in the body, particularly in the ovaries
• D-chiro-inositol (DCI) — plays a key role in insulin signalling and androgen regulation

These two forms work together in a specific ratio. In most tissues, the natural MI to DCI ratio is approximately 40:1. In women with PCOS, this ratio is frequently disrupted — DCI levels are lower, MI to DCI conversion is impaired, and the downstream effects show up as insulin resistance, irregular ovulation, and elevated androgens.

Supplementing intelligently — with the right forms, at the right ratio — helps restore what's been lost.

Inositol works by improving how cells respond to insulin, reducing the amount of insulin needed to regulate blood sugar — which in turn lowers androgen production.

Think of insulin as a key. When it arrives at a cell, it needs a messenger inside the cell to carry the signal forward. Inositol is that messenger.

When inositol levels are low or signalling is impaired — as is common in PCOS — the key fits the lock but the message never gets through. The body compensates by producing more insulin. More insulin means more androgen. More androgen means more symptoms: irregular periods, acne, unwanted hair growth, weight gain around the middle.

This is why PCOS so often feels like everything is connected. Because it is.

Restoring inositol levels doesn't just nudge one variable — it works upstream, improving insulin sensitivity, which has cascading effects across hormones, ovulation, metabolism, and skin.

Inositol improves insulin sensitivity by enhancing intracellular insulin signalling, helping the body use insulin more efficiently without needing to produce excess amounts.

If you're not sure whether insulin resistance is part of your picture, our guide to PCOS and insulin resistance breaks it down clearly.

Insulin resistance affects an estimated 50–70% of women with PCOS, including those who are lean [Diamanti-Kandarakis & Dunaif, 2012]. It's not just a "weight issue" — it's a core driver of the condition, and it can be present regardless of BMI.

Here's what the research tells us:

A study published in the International Journal of Molecular Sciences found that inositol supplementation significantly improves insulin sensitivity in women with PCOS [Unfer et al., 2016]. The effect is comparable, in some trials, to Metformin — a pharmaceutical commonly prescribed for insulin resistance — but without the gastrointestinal side effects or the long-term concern around vitamin B12 depletion.

Research published in the European Review of Medical and Pharmacological Sciences compared three treatment approaches in women with PCOS: diet alone, myo-inositol, and a combination of myo-inositol with D-chiro-inositol. The combination produced the most significant improvements in both clinical outcomes and body composition [Lagana et al., 2018].

Low DCI levels have also been directly correlated with insulin resistance. Women with PCOS are less efficient at converting MI to DCI, which means both the raw deficiency and the conversion problem compound each other [Nestler et al., 1999].

The practical takeaway: if insulin resistance is part of your PCOS picture — and statistically, there's a good chance it is — inositol addresses it at a root level rather than managing symptoms after the fact.

Inositol helps regulate androgen levels by reducing excess insulin, which is a primary driver of testosterone overproduction in PCOS.

You're not imagining it — the acne, the hair growth, the irregular cycles. These aren't just cosmetic inconveniences. They're hormonal signals.

In PCOS, elevated insulin stimulates the ovaries to overproduce androgens like testosterone. It also suppresses sex hormone-binding globulin (SHBG), a protein that normally "mops up" excess testosterone in the bloodstream. The result is more free testosterone circulating, causing more symptoms.

By improving insulin sensitivity, inositol reduces the insulin signal that drives androgen production. Multiple clinical studies have shown reductions in free testosterone and improvements in SHBG following myo-inositol supplementation [Kalra et al., 2016].

This matters not just for acne and hirsutism (we'll get to those shortly) — it matters for cycle regularity, ovulation, and long-term metabolic health.

Hormonal balance in PCOS isn't about a single magic fix. But addressing the insulin-androgen feedback loop is one of the most evidence-backed places to start.

Myo-inositol has been shown to increase ovulation frequency in women with PCOS by improving follicular signalling and reducing androgen-driven cycle disruption.

One of the most distressing aspects of PCOS — particularly for women trying to conceive, or those who simply want some predictability in their month — is irregular or absent ovulation.

The ovaries contain high concentrations of myo-inositol, which plays a critical role in follicle-stimulating hormone (FSH) signalling. When inositol levels in ovarian follicles are disrupted, follicle development becomes erratic. This is thought to be one of the reasons PCOS is associated with altered follicular dynamics.

Research has shown that daily myo-inositol supplementation leads to reduced androgen levels and increased ovulation frequency in women with PCOS [Unfer et al., 2012]. In one study, the combination of myo-inositol and folate improved ovulation rates more effectively than Metformin alone [Raffone et al., 2010].

For women not actively trying to conceive, more regular ovulation means more stable progesterone production in the luteal phase — which matters for mood, sleep, PMS symptoms, and cycle predictability.

For women who are trying to conceive, restoring ovulation is foundational. There's more on this in our guide to PCOS and fertility.

Myo-inositol can reduce acne and unwanted hair growth in PCOS by lowering androgen levels — the root cause of both symptoms.

If you've been told to "just use a better cleanser" or "try the pill" for PCOS-related acne, this section is for you.

PCOS acne is hormonal. Full stop. It's driven by elevated androgens stimulating sebaceous glands to overproduce oil, which clogs pores and triggers breakouts. The same mechanism drives hirsutism — excess facial or body hair in androgen-sensitive areas.

Studies have demonstrated that inositol supplementation reduces free androgen levels, which translates directly to improvements in both acne and hirsutism over time [Kalra et al., 2016]. It doesn't work overnight — hormonal changes take time — but addressing the root cause rather than the surface symptom is a fundamentally different approach.

It's also worth noting that for acne specifically, inositol's effect on insulin is relevant too. Blood sugar spikes trigger IGF-1, a growth factor that further stimulates sebum production. Stabilising insulin sensitivity doesn't just help your cycle — it helps your skin.

Realistic expectation: most women report gradual improvements in skin and hair over three to six months of consistent supplementation. Not overnight. Not dramatic. But real.

Myo-inositol improves egg quality and ovarian response by restoring the natural inositol balance in follicular fluid — without the side effects of pharmaceutical interventions.

For women with PCOS trying to conceive, the fertility journey can feel overwhelming. The combination of irregular ovulation, insulin resistance, and the emotional weight of uncertainty creates a lot of noise to cut through.

Here's what the evidence supports:

• Myo-inositol improves the quality of oocytes (eggs) and embryos in women with PCOS undergoing IVF [Ciotta et al., 2011]
• The combination of myo-inositol and folate improves ovulation and pregnancy rates
• Maintaining the correct MI:DCI ratio in ovarian follicles is critical — too much DCI has been shown to impair egg quality, which is why the form and ratio of any supplement matters

The ovarian follicle naturally maintains a much higher MI:DCI ratio than other tissues — some studies suggest as high as 100:1 in follicular fluid [Carlomagno & Unfer, 2011]. This is why supplementing with pure DCI or DCI-dominant products can be counterproductive for egg quality specifically.

It's also why the formulation of any inositol supplement matters. More on that below.

Myo-inositol supplementation during pregnancy may reduce the risk of gestational diabetes in women with PCOS, who are already at elevated risk.

Women with PCOS have a significantly higher risk of developing gestational diabetes (GDM). The underlying mechanism is the same: impaired insulin signalling.

A multicentre, placebo-controlled trial found that myo-inositol supplementation during pregnancy significantly reduced the incidence of gestational diabetes in women at risk [D'Anna et al., 2015]. The effect was attributed to inositol's role in improving placental insulin sensitivity.

This is an area where speaking with your healthcare provider is essential — supplementation during pregnancy should always be guided by someone who knows your full picture. But the evidence is building, and it's worth the conversation.

The scientific case for myo-inositol in PCOS has been accumulating since the early 2000s. Here's a concise overview of what the evidence currently supports:

• Insulin sensitivity: Significant improvements seen in multiple randomised controlled trials [Unfer et al., 2016]
• Androgen reduction: Reductions in free testosterone and improvements in SHBG consistently reported [Kalra et al., 2016]
• Ovulation frequency: Increased in multiple studies, comparable or superior to Metformin in some trials [Raffone et al., 2010]
• Mental health: Improvements in anxiety, depression scores, and oxidative stress markers [Jamilian et al., 2017]
• Egg quality: Improved oocyte maturity and embryo quality in IVF settings [Ciotta et al., 2011]
• Gestational diabetes prevention: Reduced incidence in at-risk women [D'Anna et al., 2015]
• Acne and hirsutism: Improvements linked to androgen reduction [Kalra et al., 2016]

This is not a supplement with thin evidence. It's one of the most robustly studied interventions in PCOS management, full stop.

Myo-inositol has demonstrated comparable effectiveness to Metformin for insulin sensitivity and ovulation in PCOS, with a significantly better tolerability and side effect profile.

Metformin is the most commonly prescribed pharmaceutical for insulin resistance in PCOS. It works. But it comes with real trade-offs:

• Gastrointestinal side effects (nausea, diarrhoea, cramping) are common, particularly in the early weeks
• Long-term use is associated with vitamin B12 depletion
• It requires a prescription and ongoing monitoring

A meta-analysis published in Gynecological Endocrinology found that myo-inositol and Metformin produced comparable short-term improvements in PCOS symptoms, with myo-inositol demonstrating better tolerability [Facchinetti et al., 2019].

This isn't to say one is always better than the other. For some women, Metformin is the right choice, and the two can be used alongside each other. But for women who want a well-evidenced, non-pharmaceutical option — or who have struggled with Metformin's side effects — inositol is a credible alternative to discuss with your doctor.

The most commonly studied and effective dose for PCOS is 2,000–4,000 mg of myo-inositol daily, often combined with 50–100 mg of D-chiro-inositol and folate.

A few things worth knowing:

Form matters. Myo-inositol should be the primary form. D-chiro-inositol plays a supporting role at the right ratio (the physiological 40:1 MI:DCI ratio is the most studied). Supplements that invert this ratio or use DCI as the dominant form have been associated with negative effects on egg quality.

Timing matters. Most studies split the dose — typically one serving in the morning and one in the evening — to maintain more stable inositol levels across the day.

Consistency matters. Inositol is not a supplement you take for two weeks and assess. Hormonal changes happen over months. Most clinical studies run for 12–24 weeks. Expect gradual, cumulative progress — not an overnight shift.

Individual response varies. The severity of your insulin resistance, your baseline inositol levels, and other factors all influence how and when you notice results. This is not a sign the supplement isn't working — it's just how hormonal physiology operates.

Always speak with your GP or healthcare provider before starting any new supplement, particularly if you're on blood sugar-lowering medication, as combining the two can lower blood glucose further than intended.

Myo-inositol is generally very well tolerated. At standard doses (up to 4,000 mg/day), side effects are uncommon.

At higher doses (above 12g/day), mild gastrointestinal symptoms — nausea, loose stools, bloating — have been reported. These are dose-dependent and typically resolve with dose reduction.

A few specific considerations:

• Blood sugar medication: If you take Metformin or other insulin-lowering drugs, speak to your doctor before adding inositol. Combined use can lower blood glucose more than intended.
• D-chiro-inositol excess: Too much DCI — particularly in supplements with an inverted MI:DCI ratio — has been linked to impaired egg quality and decreased ovarian response. Ratio matters.
• Pregnancy: Myo-inositol appears safe in pregnancy based on current evidence, but always discuss supplementation with your midwife or obstetrician.

The safety profile compares very favourably to pharmaceutical options. But "generally safe" doesn't mean "take as much as you like." Evidence-led supplementation means the right dose, the right form, and the right context.

This is where the evidence meets practice.

Myoplus is MyOva's award-winning inositol supplement, formulated specifically for women with PCOS. It contains:

• Myo-Inositol (Inositol PVP) — the clinically studied form, at a dose aligned with evidence
• Chromium Picolinate — supports healthy blood glucose metabolism, complementing inositol's effect on insulin sensitivity
• Folate (L-5-Methyltetrahydrofolate Calcium) — the bioavailable form of folate (not folic acid), critical for reproductive health and cell function, and shown in trials to enhance inositol's effect on ovulation
• Vitamin B6 (Pyridoxine HCl) — supports hormonal regulation and nervous system function, particularly relevant for PMS and mood

Every ingredient is in there for a reason. This isn't a formula built around marketing — it's built around what the research actually supports.

MyOplus won Hip & Healthy's Best Hormonal Health Supplement. It's also one of the most reviewed PCOS supplements on the UK market, with hundreds of women reporting improvements in cycle regularity, insulin-related symptoms, skin, and energy.

It's not a magic fix. But it gives your body what it's often missing — and the evidence behind why that matters is substantial.

Explore MyOplus here →

Most women begin to notice changes within 8–12 weeks, with more significant hormonal shifts typically emerging at 3–6 months of consistent use.

This is one of the most common questions — and one of the most important to answer honestly, because unrealistic expectations lead to abandoning something that's actually working.

Here's a rough timeline based on clinical evidence and common patient experience:

• Weeks 1–4: Energy levels may stabilise; some women notice reduced sugar cravings as insulin sensitivity begins to improve
• Weeks 6–12: Skin may begin to improve; some women report a more regular cycle starting to emerge
• Months 3–6: More consistent ovulation in many women; clearer hormonal improvements on blood tests; noticeable reduction in androgens for many

Hormonal physiology is slow. An egg takes approximately 90 days to mature. Androgen levels don't drop in a week. Give it time — consistent, patient time — before drawing conclusions.

Inositol is a naturally occurring compound involved in hormone signalling and insulin regulation. For women with PCOS, it improves insulin sensitivity, reduces androgen overproduction, supports ovulation, and may benefit skin, mood, and fertility. It addresses root-cause mechanisms rather than masking symptoms with short-term fixes.

Most clinical evidence supports 2,000–4,000 mg of myo-inositol daily, often combined with 50–100 mg of D-chiro-inositol and folate. Split dosing (morning and evening) is typically recommended. Always check with your healthcare provider, especially if you're on other medication.

Myo-inositol should be the primary form. D-chiro-inositol plays an important supporting role but can be harmful in excess — particularly for egg quality. The physiological MI:DCI ratio of approximately 40:1 is the most well-studied and widely recommended. Avoid supplements that invert this ratio.

Research indicates that myo-inositol improves ovulation frequency, egg quality, and embryo quality in women with PCOS. Combined with folate, it has shown improved pregnancy rates compared to Metformin in some trials. It's a well-evidenced option to discuss with a fertility specialist or GP. See our full guide to PCOS and fertility for more detail.

Inositol appears most impactful when insulin resistance is a factor, but its role in FSH signalling and ovarian function means it can be relevant even without classic insulin resistance. Women with lean PCOS have reported benefits. That said, the evidence base is strongest in insulin-resistant phenotypes.

At standard doses, inositol is very well tolerated. High doses (above 12g/day) can cause mild gastrointestinal symptoms. If you take blood sugar-lowering medication, speak to your GP before starting. Excessive DCI supplementation can impair egg quality. A well-formulated product at the right dose is key.

Most women begin to notice changes in 8–12 weeks, with more significant hormonal improvements at 3–6 months. Hormonal biology is slow — patience and consistency matter more than dose-chasing.

Your body is trying to tell you something. PCOS is not a life sentence, and it's not something you simply manage indefinitely with symptom suppression and crossed fingers.

The research on myo-inositol is some of the strongest available for any non-pharmaceutical PCOS intervention. It works at the level of the mechanism — insulin signalling, androgen regulation, follicular function — rather than just quietening symptoms on the surface.

Is it the whole picture? No. Root-cause PCOS management involves nutrition, movement, stress, sleep, and other lifestyle factors too. But for many women, inositol is a meaningful, evidence-backed piece of a strategy that finally makes their biology feel less like the enemy.

This is what I wish someone had told me earlier: hormonal literacy isn't complicated — it's just rarely taught. The more you understand what's driving your symptoms, the more agency you have to address them.

If you're ready to give your body the support the evidence points to, Myoplus is a good place to start.

• What is PCOS? A Plain-English Guide to Polycystic Ovary Syndrome
• PCOS and Insulin Resistance: Understanding the Root Cause
• PCOS and Fertility: What You Need to Know
• PCOS and Mental Health: The Connection Nobody Talks About

1. Facchinetti F, Orrù B, Grandi G, Unfer V. Short-term effects of metformin and myo-inositol in women with polycystic ovarian syndrome (PCOS): a meta-analysis of randomized clinical trials. Gynecol Endocrinol. 2019;35(3):198–206.

2. Jamilian H, Jamilian M, Foroozanfard F, et al. Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. J Psychosom Obstet Gynaecol. 2018;39(4):307–314.

3. Kalra B, Kalra S, Sharma JB. The inositols and polycystic ovary syndrome. Indian J Endocrinol Metab. 2016;20(5):720–724.

4. Unfer V, Carlomagno G, Dante G, Facchinetti F. Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials. Gynecol Endocrinol. 2012;28(7):509–515.

5. Unfer V, Facchinetti F, Orrù B, Research Group. Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocr Connect. 2017;6(8):647–658.

6. Lagana AS, Rossetti P, Buscema M, et al. Metabolism and ovarian function in PCOS women: a therapeutic approach with inositols. Int J Endocrinol. 2016;2016:6306410.

7. Raffone E, Rizzo P, Benedetto V. Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women. Gynecol Endocrinol. 2010;26(4):275–280.

8. Nestler JE, Jakubowicz DJ, Reamer P, et al. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. N Engl J Med. 1999;340(17):1314–1320.

9. Carlomagno G, Unfer V. Inositol safety: clinical evidences. Eur Rev Med Pharmacol Sci. 2011;15(8):931–936.

10. Ciotta L, Stracquadanio M, Pagano I, et al. Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial. Eur Rev Med Pharmacol Sci. 2011;15(5):509–514.

11. D'Anna R, Di Benedetto A, Scilipoti A, et al. Myo-inositol supplementation for prevention of gestational diabetes in obese pregnant women: a randomized controlled trial. Obstet Gynecol. 2015;126(2):310–315.

12. Cooney LG, Lee I, Sammel MD, Dokras A. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2017;32(5):1075–1091.

13. Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981–1030.